CME Group Inc., US12572Q1058

CME Group stock faces an oil setback before October 21 results

Published on 10/07/2026 at 16:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CME Group stock faces a regulatory setback after its 24/7 crude plan was suspended on October 6, 2026. September volume rose 22 percent year over year.

Fotorealistisches Bild eines modernen Derivate-Handelsraums mit Monitoren und Händlern
CME Group Inc. Handelsparkett mit Futures-Bildschirmen, ISIN US12572Q1058 repräsentiert den globalen Derivatemarkt, Illustration mit AI erstellt.

CME Group Inc. (ISIN US12572Q1058) was last at USD 269.68 on Nasdaq at 10:41 a.m. ET on October 7, 2026, down 0.19 percent from USD 270.18. The latest company issue concerns the suspension of its planned 24/7 crude oil contract, reported by 24/7 Wall St. on October 6, 2026.

Oil plan hits a regulatory hurdle

CME had planned a 10-barrel crude oil futures contract for round-the-clock trading. According to 24/7 Wall St., the CFTC halted the contract before launch after the American Petroleum Institute warned that continuous energy trading could complicate hedging, staffing and margin management. CME Chairman and CEO Terry Duffy said the company withdrew its filing after discussions with industry participants raised concerns about unintended market risks.

The setback affects a new product rather than CME's established core markets. CME operates futures, options and clearing services across interest rates, equity indexes, foreign exchange, commodities and other asset classes.

Trading volumes remain the counterweight

The operating picture is stronger. CME reported record average daily volume of 31.8 million contracts in September 2026, up 22 percent year over year, while third-quarter average daily volume reached 29.4 million contracts, up 16 percent. Both figures exceeded prior records set in 2024, according to StockTitan in its October 2, 2026 report.

That contrast gives investors two separate signals: a proposed energy product encountered regulatory resistance, while the existing exchange franchise continued to attract contracts across asset classes. CME is scheduled to report third-quarter 2026 results on October 21, 2026, according to Yahoo Finance.

Analyst target remains above price

Analyst expectations remain constructive but not unanimous. Markets Insider reported on October 5, 2026 that TD Cowen maintained a Buy rating and a USD 300.00 target, while the published consensus was Hold with an average target of USD 278.83. The consensus target stood USD 9.15, or 3.39 percent, above CME's USD 269.68 price.

The stock's intraday level was 18.07 percent below its 52-week high of USD 329.16 and 23.55 percent above its 52-week low of USD 218.31. The valuation leaves the October 21 earnings release as the next concrete checkpoint for whether strong trading activity is translating into higher financial results.

CME Group stock stays below its yearly high

CME Group stock was last at USD 269.68 on Nasdaq at 10:41 a.m. ET on October 7, 2026, with a market capitalization of USD 97.0 billion and volume of 257,371 shares.

CME Group stock facts

  • Company: CME Group Inc.
  • ISIN: US12572Q1058
  • Ticker: CME
  • Trading venue: Nasdaq
  • Price (as of October 7, 2026, 10:41 a.m. ET): USD 269.68
  • Market capitalization: USD 97.0 billion (as of October 7, 2026)
  • 52-week range: USD 218.31-329.16
  • Sector / Industry: Financial Services / Financial - Data and Stock Exchanges
  • Index membership: S&P 500

Upcoming dates for CME Group stock

  • October 21, 2026: Q3 2026 earnings announcement

More news and analyses on CME Group stock

Disclaimer...

en | US12572Q1058 | CME GROUP INC. | boerse | 70256977 | bgmi